biktarvy/gilead does not qualify as "better drugs"
Post# of 148110
(Total Views: 610)
Posted On: 08/14/2023 11:27:25 AM
biktarvy/gilead does not qualify as "better drugs", just made it to market sooner. my "perception" is all HIV drugs on the market have very serious side effects. even gileads ad on tv says kidney damage or failure...crazy how many approved drugs can kill you. odd isnt it?....biktarvy must be worth the risk i guess, no need for a better drug with no side effects....naaaaaah
unfortunately, holding out for common sense to take hold is no way to invest, though i still do. silly me.
unfortunately, holding out for common sense to take hold is no way to invest, though i still do. silly me.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼